This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Dr. Kathrin Lang | |
|---|---|
| Name | Kathrin Lang |
| Honorific prefix | Dr. |
| Birth place | Munich, Bavaria |
| Nationality | German |
| Occupation | Physician, researcher |
| Fields | Nephrology, internal medicine, clinical research |
| Alma mater | Ludwig Maximilian University of Munich |
Dr. Kathrin Lang Dr. Kathrin Lang is a German physician and clinical researcher known for contributions to nephrology, internal medicine, and translational clinical trials. Trained in Germany and active across European and international collaborations, she has published on renal pathophysiology, chronic kidney disease, and clinical trial methodology. Lang's work intersects academic hospitals, professional societies, and multicenter research networks.
Lang was born in Munich and completed secondary schooling in Bavaria before matriculating at the Ludwig Maximilian University of Munich where she earned a medical degree and doctoral thesis. During postgraduate training she undertook rotations and specialty training at institutions including the University Hospital of Munich and affiliated research centers, while engaging with programs linked to the German Research Foundation and the Max Planck Society. Lang pursued subspecialty fellowship training in nephrology with mentors associated with the European Renal Association and the Bundesärztekammer certification pathways, and attended advanced courses at the Karolinska Institute and workshops held by the World Health Organization and the European Society of Cardiology related to comorbid cardiovascular disease in renal patients.
Lang's early appointments combined clinical duties at tertiary hospitals with academic responsibilities at the Ludwig Maximilian University of Munich and collaborative research roles with the Helmholtz Association. She held positions in nephrology divisions that interacted with multidisciplinary teams from the Charité – Universitätsmedizin Berlin, the University of Oxford, and the University of Cambridge. Lang participated in multinational consortia funded by the European Commission Horizon programs and contributed to investigator-initiated trials coordinated with the National Institutes of Health and the European Medicines Agency. Her career includes leadership roles in clinical trial units modeled on networks such as the Clinical Trials Transformation Initiative and partnerships with biostatistics groups at the London School of Hygiene & Tropical Medicine.
Lang's peer-reviewed publications cover pathophysiology of proteinuric kidney disease, biomarkers of renal fibrosis, and therapeutic outcomes in chronic kidney disease cohorts. She has authored original articles and reviews in journals associated with the European Renal Association–European Dialysis and Transplant Association and worked with editorial boards connected to the New England Journal of Medicine, the Lancet, and specialty journals that engage the American Society of Nephrology readership. Her research includes randomized controlled trials, observational cohort analyses, and translational studies referencing molecules such as transforming growth factor-beta in contexts studied by groups at the Max Delbrück Center for Molecular Medicine and the Francis Crick Institute. Collaborations span investigators from the University of California, San Francisco, the Massachusetts General Hospital, the University of Toronto, and centers participating in the CKD Prognosis Consortium.
In clinical practice Lang worked in inpatient and outpatient nephrology services, managing patients with acute kidney injury, glomerulonephritis, and end-stage renal disease undergoing dialysis and transplant evaluation. Her clinical teams coordinated care pathways with transplantation programs at the Charité – Universitätsmedizin Berlin and dialysis networks comparable to those organized by the European Dialysis and Transplant Nurses Association. Lang contributed to guideline development processes alongside committees from the European Renal Best Practice group, linking bedside care to evidence synthesis produced by panels including members from the German Society of Nephrology and the International Society of Nephrology.
Lang received fellowships and awards recognizing early-career research excellence from organizations such as the German Society of Nephrology and competitive fellowships administered by the Humboldt Foundation. She was a recipient of travel awards to present at the American Society of Nephrology Kidney Week and received honors from university prize committees at the Ludwig Maximilian University of Munich and regional academic societies. Her contributions to collaborative trials earned acknowledgement in consortium reports funded by the European Commission and citations in guideline updates from the European Renal Association and allied bodies.
Lang has been active in professional societies including the German Society of Nephrology, the European Renal Association, and the International Society of Nephrology, and participated in working groups addressing clinical trial design, patient-reported outcomes, and biomarker validation. She engaged with advocacy initiatives linked to the World Kidney Day campaign and collaborated with patient organizations similar to Kidney Care UK and the National Kidney Foundation to promote awareness, early detection, and equitable access to renal replacement therapies. Lang mentored trainees participating in programs run by the European Society of Clinical Investigation and advised institutional review boards and ethics committees patterned on those at the University Hospital of Munich.
Outside medicine, Lang maintained interests in science communication, interdisciplinary education, and fostering research networks among European academic centers exemplified by ties to the Max Planck Society and the Helmholtz Association. Colleagues remember her for bridging clinical pragmatism with methodological rigor in nephrology research and for mentoring clinician-scientists who went on to positions at institutions such as the University of Zurich, the Imperial College London, and the University of Edinburgh. Her legacy includes contributions to multicenter datasets and clinical practice recommendations that continue to inform care pathways used across European nephrology centers.
Category:German physicians Category:Nephrologists